WENKUI KEN FANG,LIMING WANG,EVELYN G CORPUZ,KEN CHOW,WHA BIN IM
申请号：
IN3607/DELNP/2012
公开号：
IN2012DN03607A
申请日:
2012.04.25
申请国别(地区):
IN
年份:
2015
代理人:
摘要：
The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1 -phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R3 are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases systemic vascular barrier related diseases allergies and other inflammatory diseases cardiac diseases or conditions fibrosis pain and wounds.
